Watson Pharmaceuticals recalls

FDA enforcement reports naming Watson Pharmaceuticals as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Feb 13, 2013

Severity

Feb 13, 2013Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 C…Drug · Watson PharmaceuticalsFailed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).Class II